Artelo biosciences, inc. to present at the q1 virtual investor summit on march 23rd

La jolla, calif., march 11, 2021 (globe newswire) -- via investorwire – artelo biosciences, inc. (nasdaq: artl), a clinical stage biopharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that gregory gorgas, chief executive officer of artelo biosciences, will be presenting at the q1 virtual investor summit.
ARTL Ratings Summary
ARTL Quant Ranking